 WALTHAM, Mass.--BUSINESS WIRE--AlloVir, Inc. Nasdaq: ALVR, a late-clinical stage allogeneic T-cell immunotherapy company, today announced that Diana Brainard, M.D., Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference in New York on Wednesday, September 14, 2022, at 12:20 p.m. ET. A live webcast and archived replay of the fireside chat will be available on the Investors Press section of the AlloVir website at https 